RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer von Morgensztern, Daniel, Rose, Michal, Waqar, Saiama N., Morris, John, Ma, Patrick C., Reid, Thomas, Brzezniak, Christina E., Zeman, Karen G., Padmanabhan, Arvinda, Hirth, JoAnn, I. Spira, Alexander, Trepel, Jane B, Padda, Sukhmani K.

Volltext

Recalcitrant small cell lung cancer: the argument for optimism von Zeman, Karen G, Brzezniak, Christina E, Carter, Corey A

Volltext

Approach to Pancytopenia in a Deployed Service Member von Gibson, Steven J, Swanson, Benjamin, Tischbein, Carl R, Bathon, Kathleen E, Shou, Karen J, Zeman, Karen G

Volltext

Checkpoint Inhibitors in Nonsmall Cell Lung Cancer von Zeman, Karen G

Volltext

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes von Haller, Hermann, Ito, Sadayoshi, Izzo, Joseph L, Januszewicz, Andrzej, Katayama, Shigehiro, Menne, Jan, Mimran, Albert, Rabelink, Ton J, Ritz, Eberhard, Ruilope, Luis M, Rump, Lars C, Viberti, Giancarlo

Volltext

Multicenter phase II trial of RRx-001 in previously treated SCLC von Morgensztern, Daniel, Rose, Michal G., Morris, John Charles, Ma, Patrick C., Brzezniak, Christina E., Zeman, Karen Grace, Padmanabhan, Arvinda, Hirth, JoAnn, Spira, Alexander I., Wong, Ellice Yuen-Ming, Padda, Sukhmani Kaur, Waqar, Saiama Naheed

Volltext

QUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer von Padda, Sukhmani Kaur, Brzezniak, Christina E., Waqar, Saiama Naheed, Wakelee, Heather A., Ma, Patrick C., Rose, Michal G., Reid, Thomas, Spira, Alexander I., Wong, Ellice Yuen-Ming, Zeman, Karen Grace, Oronsky, Bryan, Abrouk, Nacer D, Morgensztern, Daniel

Volltext